GPx CardioID
Click to visit website
About
GPx offers innovative solutions for remote disease management through its product, CardioID, enabling doctors to monitor their patients’ blood biomarkers without requiring needles or implants. The technology utilizes predictive algorithms trained on a unique database of digital and blood biomarkers, dubbed Bloodless Blood Tests, providing continuous and actionable remote monitoring for heart failure patients. GPx is also seeking clinical partners for extensive studies in the field. Recognized for excellence, GPx has won prestigious startup pitch competitions in 2022 and 2023.
Platform
Features
• bloodless blood tests
• predictive algorithms based on proprietary data
• continuous monitoring for heart failure
• no needles or implants required
• remote monitoring of blood biomarkers
Average Rating: 0.0
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
User Ratings
No ratings available.
Sign In to Rate this Tool
Alternatives
Alio
An innovative remote monitoring platform for patients, especially designed for hemodialysis.
View Details
Featured Tools
Scalytics Connect
A federated AI framework that integrates decentralized data sources for AI development.
View Details